secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xeris Biopharma Holdings, Inc. (XERS)
CIK:        0001867096
Form:       8-K
Filed at:   2026-10-14T11:08:18+00:00
Accession:  0001867096-26-000091
Event type: litigation
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Xeris sues Torrent, Rising Pharma and others over generic KEVEYIS after '502 patent grant
--------------------------------------------------------------------------------

- Xeris Pharmaceuticals filed two patent infringement suits Oct 13, 2026 in the U.S. District Court for the District of New Jersey over generic dichlorphenamide.
- Action 1 defendants: Torrent Pharma Inc., Torrent Pharmaceuticals Limited, Cycle Pharmaceuticals Limited, Lemed Pharmacy III LLC and Lemed Specialty Pharmacy Arizona LLC.
- Action 2 defendants: Rising Pharma Holdings, Inc. and Rising Pharma Specialties Pvt. Ltd.
- Suits follow grant of U.S. Patent No. 12,758,502 relating to Xeris' KEVEYIS (dichlorphenamide) product.
- Xeris seeks infringement judgment, injunctive relief, monetary and enhanced damages, attorneys' fees and costs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867096/000186709626000091/0001867096-26-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867096/000186709626000091/xers-20261013.htm
  HTML page:      https://secwatch.observer/filing/0001867096-26-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer